Dalvastatin

CAS No. 132100-55-1

Dalvastatin( —— )

Catalog No. M34066 CAS No. 132100-55-1

Dalvastatin (RG-12561) is an orally available inhibitor of HMG-CoA reductase and cholesterol-lowering synthesis.Dalvastatin competitively inhibits rat hepatic HMG-CoA reductase with an IC50 value of 3.4 nmol / l.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 456 In Stock
10MG 653 In Stock
25MG 1026 In Stock
50MG 1376 In Stock
100MG 1851 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dalvastatin
  • Note
    Research use only, not for human use.
  • Brief Description
    Dalvastatin (RG-12561) is an orally available inhibitor of HMG-CoA reductase and cholesterol-lowering synthesis.Dalvastatin competitively inhibits rat hepatic HMG-CoA reductase with an IC50 value of 3.4 nmol / l.
  • Description
    Dalvastatin (RG-12561) inhibitor of HMG-CoA reductase and cholesterol-lowering synthesis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    HMG-CoA Reductase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    132100-55-1
  • Formula Weight
    386.5
  • Molecular Formula
    C24H31FO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=C/[C@H]1C[C@H](O)CC(=O)O1)\C2=C(CC(C)(C)CC2(C)C)C3=CC(C)=C(F)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. C M Won, et al. Epimerization and hydrolysis of dalvastatin, a new hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitor. Pharm Res. 1994 Jan;11(1):165-70.?
molnova catalog
related products
  • Aceclidine

    Aceclidine is an agent that is used for treating glaucoma by reducing intraocular pressure.

  • Lomibuvir

    Lomibuvir (VCH-222) is a selective, non-nucleoside allosteric inhibitor of HCV NS5B polymerase (RdRp) with a Kd of 17 nM. Lomibuvir inhibits the 1b/Con1 HCV subgenomic replicon with an EC 50 of 5.2 nM.

  • mTRP-2 180-188

    This peptide is a TRP-tyrosinase-related protein. Its immunization results in effective induction of antitumor immunity.